1. Isobaric tags for relative and absolute quantitation‑based proteomics reveals potential novel biomarkers for the early diagnosis of acute myocardial infarction within 3�h
   Changqing Du et al, 2019, International Journal of Molecular Medicine CrossRef
2. Activation of Angiotensin-converting Enzyme 2 Protects Against Lipopolysaccharide-induced Glial Activation by Modulating Angiotensin-converting Enzyme 2/Angiotensin (1–7)/Mas Receptor Axis
   Priya Tiwari et al, 2023, Molecular Neurobiology CrossRef
3. Cardioprotective effects of losartan and diminazene against the ischemia/reperfusion injury in hyperthyroidism rats
   Mosayeb Pashaei et al, 2024, Canadian Journal of Physiology and Pharmacology CrossRef
4. Activation of angiotensin-converting enzyme 2 ameliorates metabolic syndrome-induced renal damage in rats by renal TLR4 and nuclear transcription factor κB downregulation
   Heba F. El-Domiaty et al, 2022, Frontiers in Medicine CrossRef
5. The potential actions of angiotensin‐converting enzyme II (ACE2) activator diminazene aceturate (DIZE) in various diseases
   Tawar Qaradakhi et al, 2020, Clinical and Experimental Pharmacology and Physiology CrossRef
6. Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19
   Tomas Rajtik et al, 2021, International Journal of Molecular Sciences CrossRef
7. Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection
   Soudeh Ghafouri-Fard et al, 2020, Vascular Pharmacology CrossRef
8. The role of SARS‐CoV‐2 target ACE2 in cardiovascular diseases
   Hanzhao Zhu et al, 2021, Journal of Cellular and Molecular Medicine CrossRef